+ All Categories
Home > Documents > DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by...

DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by...

Date post: 26-Dec-2019
Category:
Upload: others
View: 3 times
Download: 0 times
Share this document with a friend
22
DRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL SECTION 1: ANAESTHETICS 1.1. General anaesthetics and oxygen 1.1.1. Inhalation medicines HALOTHANE, 250 ml, bot. ISOFLURANE, liquid, 250 ml, bot. 1.1.2. Injectable medicines KETAMINE hydrochloride, eq. 50 mg/ml base, 10 ml, vial KETAMINE hydrochloride, eq. 50 mg/ml base, 5 ml, amp. PROPOFOL, 10mg/ml, 20ml, emulsion, amp. THIOPENTAL sodium, 500 mg, powder, vial 1.2. Local anaesthetics BUPIVACAINE HCl, hyperbaric/spinal, eq.5mg/ml base, 4ml, amp EPHEDRINE hydrochloride, 30 mg/ml, 1 ml, amp. LEVOBUPIVACAINE hydrochloride eq. 5 mg/ml base,10 ml, amp LIDOCAINE 2% / EPINEPHRINE 1/80 000, 1.8 ml, cart. LIDOCAINE hydrochloride, 1%, preservative-free, 10 ml, amp LIDOCAINE, 2%, jelly, sterile, tube PHENYLEPHRINE hydrochloride, eq. 50 µg base/ ml, 10 ml amp. 1.3. Preoperative medication and sedation for short-term ATROPINE sulfate, 1 mg/ml, 1 ml, amp. DIAZEPAM, 2mg, tab. DIAZEPAM, 5 mg, tab. MIDAZOLAM, 1 mg / ml, 5 ml, amp MORPHINE hydrochloride, 10 mg/ml, 1 ml, amp. SECTION 2: MEDICINES FOR PAIN AND PALLIATIVE CARE 2.1. Non-opioids and non-steroidal anti-inflammatory medicines ACETYLSALICYLIC acid (aspirin), 300 mg, tab. ACETYLSALICYLIC acid (aspirin), 500 mg, tab. DICLOFENAC sodium, 25 mg/ml, 3 ml, amp. IBUPROFEN, 100mg/5ml, oral susp., 150 ml, bot. IBUPROFEN, 200 mg, tab. IBUPROFEN, 400 mg, tab. PARACETAMOL (acetaminophen), 10 mg/ml, 100 ml, bot. PARACETAMOL (acetaminophen), 100 mg, tab. PARACETAMOL (acetaminophen), 120mg/5ml,oral susp.,100ml bot. PARACETAMOL (acetaminophen), 500 mg, tab. PARACETAMOL (acetaminophen),10 mg/ml, 50 ml, bot. PARACETAMOL (acetaminophen),10mg/ml, 50ml, flex.bag PVC free PARACETAMOL (acetaminophen),10mg/ml,100ml, flex.bag PVC free DRUGS BY THERAPEUTIC GROUP Copyright Médecins Sans Frontières 1 INDEX IX. LISTS VIII. SDDC VII. EDDC VI. DEXO V. DEXT IV. DVAC III. DINF II. DINJ I. DORA INTRO
Transcript
Page 1: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

DRUGS BY THERAPEUTIC GROUPYou will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification

LABEL

SECTION 1: ANAESTHETICS

■ 1.1. General anaesthetics and oxygen

1.1.1. Inhalation medicinesHALOTHANE, 250 ml, bot.ISOFLURANE, liquid, 250 ml, bot.

■ 1.1.2. Injectable medicinesKETAMINE hydrochloride, eq. 50 mg/ml base, 10 ml, vialKETAMINE hydrochloride, eq. 50 mg/ml base, 5 ml, amp.PROPOFOL, 10mg/ml, 20ml, emulsion, amp.THIOPENTAL sodium, 500 mg, powder, vial

■ 1.2. Local anaestheticsBUPIVACAINE HCl, hyperbaric/spinal, eq.5mg/ml base, 4ml, ampEPHEDRINE hydrochloride, 30 mg/ml, 1 ml, amp.LEVOBUPIVACAINE hydrochloride eq. 5 mg/ml base,10 ml, ampLIDOCAINE 2% / EPINEPHRINE 1/80 000, 1.8 ml, cart.LIDOCAINE hydrochloride, 1%, preservative-free, 10 ml, ampLIDOCAINE, 2%, jelly, sterile, tubePHENYLEPHRINE hydrochloride, eq. 50 µg base/ ml, 10 ml amp.

■ 1.3. Preoperative medication and sedation for short-term ATROPINE sulfate, 1 mg/ml, 1 ml, amp.DIAZEPAM, 2mg, tab.DIAZEPAM, 5 mg, tab.MIDAZOLAM, 1 mg / ml, 5 ml, ampMORPHINE hydrochloride, 10 mg/ml, 1 ml, amp.

SECTION 2: MEDICINES FOR PAIN AND PALLIATIVE CARE

■ 2.1. Non-opioids and non-steroidal anti-inflammatory medicines ACETYLSALICYLIC acid (aspirin), 300 mg, tab.ACETYLSALICYLIC acid (aspirin), 500 mg, tab.DICLOFENAC sodium, 25 mg/ml, 3 ml, amp.IBUPROFEN, 100mg/5ml, oral susp., 150 ml, bot.IBUPROFEN, 200 mg, tab.IBUPROFEN, 400 mg, tab.PARACETAMOL (acetaminophen), 10 mg/ml, 100 ml, bot.PARACETAMOL (acetaminophen), 100 mg, tab.PARACETAMOL (acetaminophen), 120mg/5ml,oral susp.,100ml bot.PARACETAMOL (acetaminophen), 500 mg, tab.PARACETAMOL (acetaminophen),10 mg/ml, 50 ml, bot.PARACETAMOL (acetaminophen),10mg/ml, 50ml, flex.bag PVC freePARACETAMOL (acetaminophen),10mg/ml,100ml, flex.bag PVC free

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 1 INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 2: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

■ 2.2. Opioid analgesicsCODEINE phosphate, 30 mg, tab.FENTANYL citrate, eq. 0.05 mg/ml base, 2 ml, amp.MORPHINE hydrochloride, 10 mg/ml, 1 ml, amp.MORPHINE sulfate, 10 mg, immediate release breakable tab.MORPHINE sulfate, 10 mg, prolonged-release caps.MORPHINE sulfate, 10 mg, prolonged-release tab.MORPHINE sulfate, 10mg/5ml, oral sol., 100 ml, bot.MORPHINE sulfate, 30 mg, prolonged-release caps.MORPHINE sulfate, 30 mg, prolonged-release, tab.TRAMADOL hydrochloride, 100mg/ml/40 drops, 10 ml, bot.TRAMADOL hydrochloride, 50 mg, caps.TRAMADOL hydrochloride, 50 mg/ml, 2 ml, amp.

■ 2.3. Medicines for other common symptoms in palliative careAMITRIPTYLINE hydrochloride, 25 mg, tab.DIAZEPAM, 2mg, tab.DIAZEPAM, 5 mg, tab.DIAZEPAM, 5 mg/ml, 2 ml, amp.DIAZEPAM, 5mg/ml, 2 ml, emulsion, amp.FLUOXETINE hydrochloride, eq. 20 mg base, caps.HALOPERIDOL 0.5mg, tab.HALOPERIDOL, 2 mg/ml, oral sol., 100 ml, bot. with pipetteHALOPERIDOL, 5 mg, tab.HALOPERIDOL, 5 mg/ml, 1 ml, amp.HYOSCINE BUTYLBROMIDE (scopolamine butylbrom), 20 mg/1ml,ampLACTULOSE, min. 3.1 g/5ml, oral sol., bot.LOPERAMIDE hydrochloride, 2 mg, caps.LOPERAMIDE hydrochloride, 2 mg, tab.METOCLOPRAMIDE hydrochloride anhydrous, 10 mg, tab.METOCLOPRAMIDE hydrochloride, 5 mg/ml, 2 ml, amp.MIDAZOLAM, 1 mg / ml, 5 ml, ampONDANSETRON HCl, eq. 4mg/5ml base, oral sol., 50ml, bot.ONDANSETRON hydrochloride, eq. 2mg/ml base, 2 ml, amp.ONDANSETRON hydrochloride, eq. 4 mg base, tab.ONDANSETRON hydrochloride, eq. 8 mg base, tab.

SECTION 3: ANTIALLERGICS AND MEDICINES USED IN CHLORPHENAMINE maleate, 2mg/5ml, oral sol., 150 ml, bot.CHLORPHENAMINE maleate, 4 mg, tab.DEXAMETHASONE phosphate, 4 mg/ml, 1 ml, amp.EPINEPHRINE (adrenaline) tartrate, eq.1mg/ml base,1ml amp IMEPINEPHRINE (adrenaline) tartrate,eq.1 mg/ml base,1ml amp IVHYDROCORTISONE sodium succinate, eq.100mg base, powder, vialNOREPINEPHRINE (noradrenaline) tartrate,eq.1mg/ml base,4mlPREDNISOLONE, 5 mg, tab.PROMETHAZINE hydrochloride, eq. 25 mg base, tab.PROMETHAZINE hydrochloride, eq. 25 mg/ml base, 2 ml, amp.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières2

Page 3: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

SECTION 4: ANTIDOTES AND OTHER SUBSTANCES USED IN

■ 4.1. Non-specificCHARCOAL ACTIVATED, granules for oral susp., 50 g, bot.

■ 4.2. SpecificsATROPINE sulfate, 1 mg/ml, 1 ml, amp.CALCIUM GLUCONATE, 100 mg/ml, 10 ml, amp.LIPID emulsion, 20%, 250 ml, flex. bag, PVC freeNALOXONE hydrochloride, 0.4 mg/ml, 1 ml, amp.

SECTION 5: ANTICONVULSANTS / ANTIEPILEPTICSCARBAMAZEPINE, 200 mg, tab.MAGNESIUM sulfate, 0.5 g/ml, 10 ml, amp.PHENOBARBITAL sodium, 200 mg/ml, 1 ml, amp.PHENOBARBITAL sodium, 54.75 mg/ml, 4 ml, powder,vial+solventPHENOBARBITAL, 5.4%, 1 mg/drop, oral sol., 30 ml, bot.PHENOBARBITAL, 50 mg, tab.PHENOBARBITAL, 60 mg, tab.PHENYTOIN sodium, 100 mg, tab.PHENYTOIN sodium, 50 mg/ml, 5ml, amp.VALPROATE SODIUM, 200 mg, gastro-resistant tab.VALPROATE SODIUM, 500 mg, gastro-resistant tab.

SECTION 6: ANTI-INFECTIVE MEDICINES

■ 6.1. Anthelminthics

6.1.1. Intestinal anthelminthicsALBENDAZOLE, 400 mg, tab.IVERMECTIN (scabies + other indic.), 3 mg, tab.MEBENDAZOLE, 100 mg, tab.PRAZIQUANTEL, 150 mg, tab.PRAZIQUANTEL, 600 mg, tab.

6.1.2. AntifilarialsALBENDAZOLE, 400 mg, tab.DIETHYLCARBAMAZINE citrate, eq. 100mg base, break. tab.IVERMECTIN (onchocerciasis), 3 mg, tab.IVERMECTIN (onchocerciasis, mass distribution), 3 mg, tab.

6.1.3. Antischistosomals and antitrematode medicinesPRAZIQUANTEL, 600 mg, tab.TRICLABENDAZOLE, 250 mg, tab.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 3 INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 4: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

■ 6.2. Antibacterials

6.2.1. Beta Lactam medicinesAMOXICILLIN 1g / CLAVULANIC acid 200mg, powderAMOXICILLIN 400mg / CLAV.ac. 57mg/5ml, powd.oral susp. 70mlAMOXICILLIN 500 mg / CLAVULANIC acid 125 mg, tab.AMOXICILLIN 500mg / CLAVULANIC acid, 62.5 mg, tab.AMOXICILLIN 875mg / CLAVULANIC acid 125mg, tab.AMOXICILLIN, 125mg/5ml, powder oral susp., 100 ml, bot.AMOXICILLIN, 250 mg, caps.AMOXICILLIN, 250 mg, disp. tab.AMOXICILLIN, 250 mg, tab.AMOXICILLIN, 500 mg, tab.AMPICILLIN, 1 g, powder, vialAMPICILLIN, 500 mg, powder, vialBENZATHINE BENZYLPENICILLIN, 1.2 M IU, powder, vial+ solventBENZATHINE BENZYLPENICILLIN, 2.4 M IU, powder, vial+ solventBENZYLPENICILLIN (peni G, crystal peni), 1 MIU, powder,vialBENZYLPENICILLIN (peni G, crystal peni), 5 MIU, powder,vialCEFALEXIN, 125mg/5ml, granules oral susp., 100 ml, bot.CEFALEXIN, 250 mg, caps.CEFAZOLIN, 1 g, (IV), powder, vialCEFIXIME, 100mg/5ml, powder for oral susp., 40ml, bot.CEFIXIME, 100mg/5ml, powder for oral susp., 60 ml, bot.CEFIXIME, 200 mg, tab.CEFOTAXIME sodium, eq. 250 mg base, vialCEFOTAXIME sodium, eq. 500 mg base, vialCEFTRIAXONE sodium, eq. 1 g base, powder, vialCEFTRIAXONE sodium, eq. 250 mg base, powder, vialCEFTRIAXONE sodium, eq.1 g base, powder, vial + lidocaine IMCEFTRIAXONE sodium, eq.250mg base, powd, vial + lidocaine IMCLOXACILLIN sodium, eq. 250 mg base, caps.CLOXACILLIN sodium, eq. 500 mg base, powder, vial IVCLOXACILLIN sodium, eq. 500 mg base, caps.IMIPENEM 500 mg / CILASTATIN sodium 500 mg, powder, vialPENICILLIN PROCAINE 3 MIU / PENI G 1 MIU, (PPF) powder,vialPHENOXYMETHYLPENICILLIN, 125mg/5ml, powd.oral sol,100ml, botPHENOXYMETHYLPENICILLIN, 250 mg, tab.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières4

Page 5: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

6.2.2. Other antibacterialsAMIKACIN sulfate, eq. 250 mg/ml base, 2 ml, amp.AZITHROMYCIN, 200mg/5ml, powder oral susp., 15ml, bot.AZITHROMYCIN, 200mg/5ml, powder oral susp., 30ml, bot.AZITHROMYCIN, 250 mg, tab.AZITHROMYCIN, 500 mg, tabCHLORAMPHENICOL, 1 g powder, vialCHLORAMPHENICOL, 250 mg, caps.CIPROFLOXACIN hydrochloride, eq. 250 mg base, tab.CIPROFLOXACIN hydrochloride, eq. 500 mg base, tab.CIPROFLOXACIN salt, eq. 2mg/ml base,100ml,flex.bag PVC freeCIPROFLOXACIN salt, eq. 2mg/ml base,100ml,semi-r.bot PVCfreeCIPROFLOXACIN, 250mg/5ml, gran.+ solvent oral suspCLARITHROMYCIN, 500 mg, tab.CLINDAMYCIN hydrochloride, eq. 150 mg base, caps.CLINDAMYCIN hydrochloride, eq. 300 mg base, caps.CLINDAMYCIN phosphate, eq. 150mg base/ml, 2 ml, amp.COTRIMOXAZOLE, 100 mg / 20 mg, disp. tab.COTRIMOXAZOLE, 100 mg / 20 mg, tab.COTRIMOXAZOLE, 200mg/40mg/5ml, oral susp,100 ml, bot.COTRIMOXAZOLE, 400 mg / 80 mg, tab.COTRIMOXAZOLE, 800 mg / 160 mg, tab.COTRIMOXAZOLE, 80mg/16mg/ml, 5 ml for infusion, vialDOXYCYCLINE salt, eq. 100 mg base, tab.ERYTHROMYCIN ethylsucc. 125mg/5ml,powder oral susp.100ml,botERYTHROMYCIN lactobionate, eq. to 1 g base, pdr, vialERYTHROMYCIN stearate, eq. 250 mg base, tab.ERYTHROMYCIN stearate, eq. 500 mg base, tab.FOSFOMYCIN trometamol, eq. 3 g base, sachetGENTAMICIN sulfate, eq. 10mg/ml base, 2ml, amp.GENTAMICIN sulfate, eq. 40 mg/ml base, 2 ml, amp.METRONIDAZOLE benzoate, eq.200mg/5ml base, oral susp., 100mlMETRONIDAZOLE, 250 mg, tab.METRONIDAZOLE, 5 mg/ml, 100 ml, flex. bag PVC freeMETRONIDAZOLE, 5 mg/ml, 100 ml, semi-rigid bot. PVC freeMETRONIDAZOLE, 500 mg, tab.SPECTINOMYCIN hydrochloride, eq. 2 g base, powder, vialSPECTINOMYCIN hydrochloride, eq.2g base, powder,vial+SOLVENTTINIDAZOLE, 500 mg, tab.

6.2.3. Antileprosy medicinesCLOFAZIMINE, 100 mg, soft caps.CLOFAZIMINE, 50 mg, soft caps.DAPSONE, 100 mg, break. tab.DAPSONE, 25 mg, tab.DAPSONE, 50 mg, tab.RIFAMPICIN (R), 150 mg, tab., blisterRIFAMPICIN (R), 300 mg, caps. blister

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 5 INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 6: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

6.2.4. Antituberculosis medicinesAMIKACIN sulfate, eq. 250 mg/ml base, 2 ml, amp.BEDAQUILINE, 100 mg, tab.CAPREOMYCIN sulfate, eq. 1 g base, powder, vialCLOFAZIMINE, 100 mg, soft caps.CLOFAZIMINE, 50 mg, soft caps.CYCLOSERINE, 250 mg, caps. blisterDELAMANID, 50 mg, tab., blisterE 275 mg / H 75 mg / R 150 mg, tab., blisterE 275 mg / H 75 mg / Z 400 mg / R 150 mg, tab., blisterETHAMBUTOL hydrochloride (E), eq. 100 mg base, tab. blisterETHAMBUTOL hydrochloride (E), eq. 400 mg base, tab. blisterETHIONAMIDE, 125 mg, tab., blisterETHIONAMIDE, 250 mg, tab., blisterH 50 mg / R 75 mg, disp. tab., blisterH 50 mg / Z 150 mg / R 75 mg, disp. tab., blisterH 60 mg / R 60 mg, disp. tab., blisterH 75 mg / R 150 mg, tab., blisterISONIAZID (H), 100 mg, breakable tab., blisterISONIAZID (H), 300 mg, tab., blisterISONIAZID (H), 50 mg/5ml, oral sol., 500 ml, bot.KANAMYCIN sulfate, eq. 0.250g/ml base, 2 ml, amp.KANAMYCIN sulfate, eq. 0.250g/ml base, 4 ml, amp.KANAMYCIN sulfate, eq. 0.5 g base, powder, vialKANAMYCIN sulfate, eq. 1 g base, powder, vialLEVOFLOXACIN, 250 mg, tab.LEVOFLOXACIN, 500 mg, tab.LINEZOLID, 600 mg, coated tab.MOXIFLOXACIN hydrochloride, eq 400 mg base, tab.PARA-AMINOSALICYLATE sodium, 5.52 g, powder oral sol., sach.PARA-AMINOSALICYLATE sodium, del.rel.gran 60%w/w, 100g jarPARA-AMINOSALICYLATE sodium, del.rel.gran 60%w/w, 9.2g sach.PARA-AMINOSALICYLIC acid (PAS), delayed rel.gran, 4 g, sach.PARA-AMINOSALICYLIC acid (PAS),del.rel.gran, 4g, sach.(25°C)PROTHIONAMIDE, 250 mg, tab.PYRAZINAMIDE (Z), 150mg, disp. tab., bulkPYRAZINAMIDE (Z), 400 mg, tab., blisterRIFABUTIN, 150 mg, caps.RIFAMPICIN (R), 150 mg, tab., blisterRIFAMPICIN (R), 300 mg, caps. blisterSTREPTOMYCIN sulfate, eq. 1 g base, powder, vial

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières6

Page 7: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

■ 6.3. Antifungal medicinesAMPHOTERICIN B conventional, 50 mg, powder, vialAMPHOTERICIN B liposomal complex, 50 mg,powder, vialCLOTRIMAZOLE, 500 mg, vaginal tab. + applicatorFLUCONAZOLE, 100 mg, caps.FLUCONAZOLE, 2 mg/ml, 100 ml, flexible bag PVC freeFLUCONAZOLE, 2 mg/ml, 100 ml, semi-rigid bot. PVC freeFLUCONAZOLE, 200 mg, caps.FLUCONAZOLE, 50 mg, caps.FLUCONAZOLE, 50mg/5ml, powder oral susp., bot.FLUCYTOSINE, 500 mg, tab.GRISEOFULVIN, 125 mg, tab.GRISEOFULVIN, 500 mg, tab.ITRACONAZOLE, 100 mg, caps.MICONAZOLE, 2%, oral gel, 40g, tubeMICONAZOLE, 2%, oral gel, 80g, tubeNYSTATIN, 100,000 IU/ml, oral susp.

■ 6.4. Antiviral medicines

6.4.1. Antiherpes medicinesACICLOVIR sodium, eq. 250 mg base, powder, vialACICLOVIR, 200 mg, tab.ACICLOVIR, 800 mg, tab.

6.4.2. Antiretrovirals

6.4.2.1. Nucleoside / nucleotide reverse transcriptase inhibitorsABACAVIR sulfate (ABC), 60 mg, disp. tab.ABACAVIR sulfate (ABC), eq. 300 mg base, tab.LAMIVUDINE (3TC), 150 mg, tab.LAMIVUDINE (3TC), 50mg/5ml, oral sol., 100 ml, bot.LAMIVUDINE (3TC), 50mg/5ml, oral sol., 240 ml, bot.ZIDOVUDINE (AZT), 300 mg, tab.ZIDOVUDINE (AZT), 50mg/5ml, oral sol., 100ml bot.ZIDOVUDINE (AZT), 50mg/5ml, oral sol., 200 ml, bot.ZIDOVUDINE (AZT), 50mg/5ml, oral sol., 240 ml, bot.

6.4.2.2. Non-nucleoside reverse transcriptase inhibitorsEFAVIRENZ (EFV), 200 mg, break. tab.EFAVIRENZ (EFV), 200 mg, caps.EFAVIRENZ (EFV), 200 mg, tab.EFAVIRENZ (EFV), 600 mg, tab.ETRAVIRINE (ETV), 100 mg, tab.NEVIRAPINE (NVP), 200 mg, tab.NEVIRAPINE (NVP), 50 mg, disp. tab.NEVIRAPINE (NVP), 50mg/5ml, oral susp., 100 ml, bot.NEVIRAPINE (NVP), 50mg/5ml, oral susp., 240 ml, bot.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 7 INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 8: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

6.4.2.3. Protease inhibitorsATAZANAVIR sulfate (ATV), 200 mg, caps.ATV 300 mg / r 100 mg, tab.DARUNAVIR ethanolate (DRV), eq. 300 mg base, tab.DARUNAVIR ethanolate (DRV), eq. 600 mg base, tab.DARUNAVIR ethanolate (DRV), eq. 75 mg base, tab.LPV / r 400/100mg/5ml, oral sol., 160 ml, bot.LPV / r 400/100mg/5ml, oral sol., 60 ml, bot.LPV 100 mg / r 25 mg, gastro-resistant tab.LPV 200 mg / r 50 mg, tab.LPV 40 mg / r 10 mg, pellets-in-a-capsuleRITONAVIR (r), 100 mg, tab.RITONAVIR (r), 25 mg, tab.RITONAVIR (r), 400 mg/5ml, oral sol., 90 ml, bot.

6.4.2.4. Integrase inhibitorsDOLUTEGRAVIR sodium (DTG), eq. 50 mg base, tab.RALTEGRAVIR potassium (RAL), eq. 100 mg base, chew. tab.RALTEGRAVIR potassium (RAL), eq. 25mg base, chew. tab.RALTEGRAVIR potassium (RAL), eq. 400 mg base, tab.

6.4.2.5. Medicines for prevention of HIV-related opportunistic infec-INH 300mg/ PYRIDOXINE 25mg/ SMX 800mg / TMP 160mg, tab.

6.4.2.6. Antiretroviral fixed-dose combinationsABC 60 mg / 3TC 30 mg, disp. tab.ABC 600 mg / 3TC 300 mg, tab.ABC 120 mg / 3TC 60 mg, disp. tab.ABC 60 mg / 3TC 30 mg / AZT 60 mg, tab.ABC 300 mg / 3TC 150 mg / AZT 300 mg, tab.TDF 300 mg / FTC 200 mg / EFV 600 mg, tab.TDF 300 mg / FTC 200 mg, tab.TDF 300 mg / 3TC 300 mg, tab.TDF 300 mg / 3TC 300 mg / EFV 600 mg, tab.AZT 60 mg / 3TC 30 mg, tab.AZT 60 mg / 3TC 30 mg , disp. tab.AZT 300 mg / 3TC 150 mg, tab.AZT 300 mg / 3TC 150mg x 2 + EFV 600 mg x 1 tab.,coblisterAZT 300 mg / 3TC 150mg x 60 + EFV 600 mg x 30 tab., co-packAZT 60 mg / 3TC 30 mg / NVP 50 mg, dispersible tab.AZT 300 mg / 3TC 150 mg / NVP 200 mg, tab.

6.4.3. Other antiviralsGANCICLOVIR sodium, eq.500 mg base, powder, vial fr infusionOSELTAMIVIR phosphate, eq. 75 mg base, caps.RIBAVIRIN, 100 mg/ml, 12 ml, amp.RIBAVIRIN, 200 mg, caps.RIBAVIRIN, 200mg/5ml, oral sol., 100 ml, bot.RIBAVIRIN, 400 mg, tab.VALGANCICLOVIR hydrochloride, eq. 450 mg base, tab.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières8

Page 9: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

6.4.4. Antihepatitis medicines

6.4.4.1. Medicines for hepatitis BTENOFOVIR DISOPROXIL fumarate 300mg, eq. 245mg base, tab.

6.4.4.2. Medicines for hepatitis C6.4.4.2.1. Nucleotide polymerase inhibitors

SOFOSBUVIR, 400 mg, tab.

6.4.4.2.3. NS5A inhibitorsDACLATASVIR dihydrochloride (DCV), eq. 30 mg base, tab.DACLATASVIR dihydrochloride (DCV), eq. 60 mg base, tab.

6.4.4.2.5. Other antivirals for hepatitis CINTERFERON pegylated alpha 2A, 180µg/0.5ml, syr.INTERFERON pegylated alpha 2A, 180µg/ml, 1ml, vialINTERFERON pegylated alpha 2B, 120 µg, powder+ solvent 0.5mlINTERFERON pegylated alpha 2B, 80 µg, powder+ solvent 0.5mlRIBAVIRIN, 100 mg/ml, 12 ml, amp.RIBAVIRIN, 200 mg, caps.RIBAVIRIN, 200mg/5ml, oral sol., 100 ml, bot.RIBAVIRIN, 400 mg, tab.

6.4.4.2.6. Medicines for hepatitis C Fixed Dose CombinationsLEDIPASVIR 90 mg / SOFOSBUVIR 400 mg, tab.SOFOSBUVIR (SOF) 400mg / VELPATASVIR (VEL) 100mg, tab.

■ 6.5. Antiprotozoal medicines

6.5.1. Antiamoebic and antigiardiasis medicinesMETRONIDAZOLE benzoate, eq.200mg/5ml base, oral susp., 100mlMETRONIDAZOLE, 250 mg, tab.METRONIDAZOLE, 5 mg/ml, 100 ml, flex. bag PVC freeMETRONIDAZOLE, 5 mg/ml, 100 ml, semi-rigid bot. PVC freeMETRONIDAZOLE, 500 mg, tab.TINIDAZOLE, 500 mg, tab.

6.5.2. Antileishmaniasis medicinesAMPHOTERICIN B conventional, 50 mg, powder, vialAMPHOTERICIN B liposomal complex, 50 mg,powder, vialMEGLUMINE ANTIMONIATE, pentaval. antimony 81 mg/ml, 5ml, ampMILTEFOSINE, 10 mg, caps.MILTEFOSINE, 50 mg, caps.PAROMOMYCIN sulfate, eq. 375 mg/ml base, 2 ml, ampPENTAMIDINE isetionate, 300 mg, powder, vialSODIUM STIBOGLUCONATE, pentaval.antimony 100mg/ml 100ml vialSODIUM STIBOGLUCONATE, pentaval.antimony 100mg/ml, 30ml vial

6.5.3. Antimalarial medicines

6.5.3.1. For curative treatmentARTESUNATE 60 mg, powder,vial +NaHCO3 5% 1ml +NaCl 0.9% 5mlAL 20/120 mg, 6 disp. tab., blister, 5-14 kg

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 9 INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 10: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

AL 20/120 mg, 12 disp. tab., blister, 15-24 kgAL 20/120 mg, 18 tab., blister, 25-34 kgAL 20/120 mg, 24 tab., blister, >35 kgAL 80/480 mg, 6 tab., blister, >35 kgAS 25 mg / AQ eq. 67.5 mg base, 3 tab, blister, 4.5-8 kgAS 50 mg / AQ eq. 135 mg base, 3 tab, blister, 9-17 kgAS 100 mg / AQ eq. 270 mg base, 3 tab, blister, 18-35 kgAS 100 mg / AQ eq. 270 mg base, 6 tab, blister, >36 kgAS 25 mg / MQ eq. 50 mg base, 3 tab, blister, 5-8 kgAS 25 mg / MQ eq. 50 mg base, 6 tab, blister, 9-17 kgAS 100 mg / MQ eq. 200 mg base, 3 tab, blister, 18-29 kgAS 100 mg / MQ eq. 200 mg base, 6 tab, blister, >30 kgAS 3 x 50 mg + SP 1 x 500/25 mg, tab.,coblister, <25 kgAS 6 x 50 mg + SP 2 x 500/25 mg, tab., coblister, 25-50 kgAS 6 x 100 mg + SP 3 x 500/25 mg, tab., coblister, >50 kgCHLOROQUINE, 100 mg base, (161 mg phosphate), tab.CHLOROQUINE, 155 mg base, (250 mg phosphate), tab.DHA 20 mg / PPQ 160 mg, 3 tab., blister, 5-12 kgDHA 40 mg / PPQ 320 mg, 3 tab., blister, 13-23 kgDHA 40 mg / PPQ 320 mg, 6 tab., blister, 24-34 kgDHA 40 mg / PPQ 320 mg, 9 tab., blister, 35-74 kgDHA 40 mg / PPQ 320 mg, 12 tab., blister, 75-100 kgDOXYCYCLINE salt, eq. 100 mg base, tab.MEFLOQUINE hydrochloride, eq. 250 mg base, tab.PRIMAQUINE diphosphate, eq. 15 mg base, tab.QUININE sulfate, 300 mg, tab.SP 1x250/12.5mg + AQ 3x eq.75mg base, tab, coblister,4.5-8kgSP 1x250/12.5mg + AQ 3x eq.76.5mg base,disp.tab,cobl,4.5-8kgSP 1x500/25mg + AQ 3x eq.150mg base, tab, coblister,9-17kgSP 1x500/25mg + AQ 3x eq.153mg base, disp.tab., cobl.,9-17kgSULFADOXINE, 500 mg / PYRIMETHAMINE, 25 mg, tab.

6.5.3.2. For prophylaxisATOVAQUONE 250mg / PROGUANIL HCl 100mg, tab, blister, >40 kgATOVAQUONE 62.5mg/ PROGUANIL HCl 25mg, tab, blister, 11-40kgDOXYCYCLINE salt, eq. 100 mg base, tab.MEFLOQUINE hydrochloride, eq. 250 mg base, tab.

6.5.4. Antipneumocystosis and antitoxoplasmosis medicinesCOTRIMOXAZOLE, 100 mg / 20 mg, disp. tab.COTRIMOXAZOLE, 100 mg / 20 mg, tab.COTRIMOXAZOLE, 200mg/40mg/5ml, oral susp,100 ml, bot.COTRIMOXAZOLE, 400 mg / 80 mg, tab.COTRIMOXAZOLE, 800 mg / 160 mg, tab.COTRIMOXAZOLE, 80mg/16mg/ml, 5 ml for infusion, vialDAPSONE, 100 mg, break. tab.DAPSONE, 25 mg, tab.DAPSONE, 50 mg, tab.PENTAMIDINE isetionate, 300 mg, powder, vialPYRIMETHAMINE, 25 mg, tab.SULFADIAZINE, 500 mg, tab.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières10

Page 11: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

LABEL

6.5.5. Antitrypanosomal medicines6.5.5.1. African trypanosomiasis

EFLORNITHINE hydrochloride, eq. 200 mg/ml base, 100 ml, vialMELARSOPROL, 36 mg/ml, 5 ml, amp.NIFURTIMOX, 120 mg, tab.PENTAMIDINE isetionate, 300 mg, powder, vial

6.5.5.2. American trypanosomiasisBENZNIDAZOLE, 100 mg, tab.NIFURTIMOX, 120 mg, tab.

■ 6.6. Insect repellentsD.E.E.T., anti-mosquito repellent lotion

■ 6.7. ScabicidesIVERMECTIN (scabies + other indic.), 3 mg, tab.

SECTION 7: ANTIMIGRAINE MEDICINES

■ 7.1. For treatment of acute attackACETYLSALICYLIC acid (aspirin), 300 mg, tab.ACETYLSALICYLIC acid (aspirin), 500 mg, tab.IBUPROFEN, 200 mg, tab.IBUPROFEN, 400 mg, tab.PARACETAMOL (acetaminophen), 100 mg, tab.PARACETAMOL (acetaminophen), 120mg/5ml,oral susp.,100ml bot.PARACETAMOL (acetaminophen), 500 mg, tab.

SECTION 8: ANTINEOPLASTIC AND IMMUNOSUPPRESSIVES

■ 8.2. Cytotoxic and adjuvant medicinesBLEOMYCIN sulfate, eq. 15 mg base, powder, vialCALCIUM FOLINATE, eq. 15 mg, folinic acid, tab.DOXORUBICIN HCl, pegylated liposomal, 2 mg/ml, 10 ml vialDOXORUBICIN HCl, pegylated liposomal, 2 mg/ml, 25 ml vialVINCRISTINE sulfate, 1 mg/ml, 1 ml, vialVINCRISTINE sulfate, 1 mg/ml, 2 ml, vial

■ 8.3. Hormones and antihormonesDEXAMETHASONE phosphate, 4 mg/ml, 1 ml, amp.HYDROCORTISONE sodium succinate, eq.100mg base, powder, vialPREDNISOLONE, 5 mg, tab.

SECTION 9: ANTIPARKINSONISM MEDICINESBIPERIDEN hydrochloride, 2 mg, tabLEVODOPA 250 mg / CARBIDOPA 25 mg, tab.TRIHEXYPHENIDYL hydrochloride, 2 mg, tab.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 11 INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 12: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

SECTION 10: MEDICINES AFFECTING THE BLOOD

■ 10.1. Antianaemia medicinesEPOETIN ALFA, 10 000 IU/ml, 1 ml, graduated syringeFERROUS salt eq. 60 mg iron / FOLIC acid 0.4 mg, tabFERROUS salt eq. 65 mg iron / FOLIC acid 0.4 mg, tabFERROUS salt, eq. +/- 65 mg iron, tab.FERROUS salt, eq. iron 45mg/5ml, syrup, 200ml, bot.FERROUS salt, eq. iron 45mg/5ml, syrup, 300ml, bot.FOLIC acid, 5 mg, tab.

■ 10.2. Medicines affecting coagulationHEPARIN SODIUM, 5 000 IU/ml, 5ml, amp.NADROPARIN calcium, 1900 IU / 0.2 ml, syringeNADROPARIN calcium, 2850 IU / 0.3 ml, syringeNADROPARIN calcium, 3800 IU / 0.4 ml, syringePHYTOMENADIONE (vitamin K1), 10 mg/ml, 1 ml, amp.PHYTOMENADIONE (vitamin K1), 10mg/ml (2mg/0.2ml), 0.2ml amp.PROTAMINE sulfate, 10 mg/ml, 5 ml, amp.TRANEXAMIC ACID, 100 mg / ml, 5 ml amp.TRANEXAMIC ACID, 500 mg tab

SECTION 11: BLOOD PRODUCTS AND PLASMA SUBSTITUTES

■ 11.2. Plasma-derived medicines

11.2.1. Human immunoglobulinsIMMUNOGLOBULIN HUMAN ANTITETANUS, 250 IU/ml, syr.IMMUNOGLOBULIN, HUMAN, ANTIRABIES, 150 IU/ml, 5 ml syringe

■ 11.3. Plasma substitutesPLASMA SUBSTITUTE, gelatin, 500 ml, flex.bag, PVCPLASMA SUBSTITUTE, gelatin, 500 ml, flex.bag, PVC freePLASMA SUBSTITUTE, gelatin, 500 ml, semi-rigid bot, PVC free

SECTION 12: CARDIOVASCULAR MEDICINES

■ 12.1. Antianginal medicinesBISOPROLOL fumarate, 2.5 mg, break. tab.BISOPROLOL fumarate, 5 mg, tab.GLYCERYL TRINITRATE, 0.5 mg, sublingual tab.ISOSORBIDE DINITRATE, 1 mg/ml, 10 ml, amp.ISOSORBIDE DINITRATE, 5 mg, sublingual tab.VERAPAMIL hydrochloride, 40 mg, tab.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières12

LABEL

Page 13: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

■ 12.2. Antiarrhythmic medicinesAMIODARONE hydrochloride, 50 mg/ml, 3 ml, amp.BISOPROLOL fumarate, 2.5 mg, break. tab.BISOPROLOL fumarate, 5 mg, tab.DIGOXIN, 0.25 mg, tab.DIGOXIN, 0.25 mg/ml, 2 ml, amp.EPINEPHRINE (adrenaline) tartrate, eq.1mg/ml base,1ml amp IMEPINEPHRINE (adrenaline) tartrate,eq.1 mg/ml base,1ml amp IVNOREPINEPHRINE (noradrenaline) tartrate,eq.1mg/ml base,4mlVERAPAMIL hydrochloride, 2.5 mg/ml, 2 ml, amp.VERAPAMIL hydrochloride, 40 mg, tab.

■ 12.3. Antihypertensive medicinesBISOPROLOL fumarate, 2.5 mg, break. tab.BISOPROLOL fumarate, 5 mg, tab.ENALAPRIL maleate, 5 mg, tab.HYDRALAZINE hydrochloride, 20 mg, powder, amp.HYDROCHLOROTHIAZIDE, 50 mg, tab.LABETALOL hydrochloride, 100 mg, tab.LABETALOL hydrochloride, 200 mg, tab.LABETALOL hydrochloride, 5 mg/ml, 20 ml amp.METHYLDOPA, 250 mg, tab.NICARDIPINE hydrochloride, 1mg / ml, 10 ml, amp.

■ 12.4. Medicines used in heart failureBISOPROLOL fumarate, 2.5 mg, break. tab.BISOPROLOL fumarate, 5 mg, tab.DIGOXIN, 0.25 mg, tab.DIGOXIN, 0.25 mg/ml, 2 ml, amp.DOPAMINE hydrochloride, 40 mg/ml, 5 ml, amp.ENALAPRIL maleate, 5 mg, tab.FUROSEMIDE, 10 mg/ml, 2 ml, amp.FUROSEMIDE, 20 mg, tab.FUROSEMIDE, 40 mg, tab.HYDROCHLOROTHIAZIDE, 50 mg, tab.

■ 12.5. Antithrombotic medicines

12.5.1. Anti-platelet medicinesACETYLSALICYLIC acid (aspirin), 75 mg, gastro-resistant tab.

■ 12.6. Lipid-lowering agentsATORVASTATIN, 10 mg, tab.ATORVASTATIN, 80 mg, tab.

SECTION 13: DERMATOLOGICAL MEDICINES (TOPICAL)ZINC OXIDE, 10%, ointment, 100 g, tube

■ 13.1. Antifungal medicinesBENZOIC ACID 6% / SALICYLIC ACID 3%, ointment, 40 g, tubeMICONAZOLE nitrate, 2%, cream, 30 g, tube

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 13

LABEL

INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 14: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

■ 13.2. Anti-infective medicinesCHLORHEXIDINE digluconate 0.2%, mouthwash, sol., 300ml, bot.MUPIROCIN 2%, ointment, 15 g, tubeSODIUM BICARBONATE, 1 kg, for mouthwashesSULFADIAZINE SILVER, 1%, cream, sterile, 50 g, tubeSULFADIAZINE SILVER, 1%, cream, sterile, 500 g, jar

■ 13.3. Anti-inflammatory and antipruritic medicinesANTIPRURITIC CREAM, after mosquito bites, tubeCALAMINE, 15%, lotion, 500 ml, bot.HYDROCORTISONE (acetate or base), 1%, cream, 15 g, tubeHYDROCORTISONE (acetate or base), 1%, ointment, 15 g, tube

■ 13.4. Medicines affecting skin differentiation and proliferationPODOPHYLLOTOXIN, 0.5%, solution, 3.5ml, + 30 applicator tipsSILVER NITRATE, 40%, pencil

■ 13.5. Scabicides and pediculicidesBENZYL BENZOATE, 25%, lotion, 1 l, bot.MALATHION, 500 mg/100 ml, lotion, bot.PERMETHRIN, 0.5 %, powder, human body, 500 g, powdering botPERMETHRIN, 1 %, lotion, bot.PERMETHRIN, 5%, cream, tube

SECTION 14: DIAGNOSTIC AGENTS

■ 14.1. Ophthalmic medicinesFLUORESCEIN, 0.5%, eye drops, ster, 0.4 ml, unidose, amp.FLUORESCEIN, 2 %, eye drops, sterile, 0.5ml, unidose, ampTROPICAMIDE, 0.5%, eye drops, sterile, 0.4 ml, unidose, amp.

SECTION 15: DISINFECTANTS AND ANTISEPTICS

■ 15.1. AntisepticsCHLORHEXIDINE 2%, alcohol solution, 250 ml, bot.CHLORHEXIDINE digluconate 5%, solution, 1 l, bot.POLYVIDONE IODINE, 10%, solution, 200 ml, dropper bot.POLYVIDONE IODINE, surgical scrub, 4 %, 125 ml, bot.POLYVIDONE IODINE, surgical scrub, 7.5 %, 500 ml, bot.

■ 15.2. DisinfectantsALCOHOL-BASED HAND RUB, solution, 100 ml, bot.ALCOHOL-BASED HAND RUB, solution, 500 ml, bot.CHLORINE, 1 g (NaDCC / dichloroisocyan. sodium 1.67 g), tab.DETERGENT/DISINFECTANT for surfaces, 1 l tinDETERGENT/DISINFECTANT for surfaces, 2 l tin + dosing pumpDISINFECTANT for med. equip., QA combi, 5l tin + dosing pump

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières14

LABEL

Page 15: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

SECTION 16: DIURETICSFUROSEMIDE, 10 mg/ml, 2 ml, amp.FUROSEMIDE, 20 mg, tab.FUROSEMIDE, 40 mg, tab.HYDROCHLOROTHIAZIDE, 50 mg, tab.SPIRONOLACTONE, 25 mg, tab.

SECTION 17: GASTROINTESTINAL MEDICINESHYOSCINE BUTYLBROMIDE (scopolamine butylbromide), 10 mg, tab

■ 17.1. Antiulcer medicinesALUMINIUM hydroxide 400mg / MAGNESIUM hydroxide 400mg, tab.CIMETIDINE, 200 mg, effervescent tab.OMEPRAZOLE sodium, eq. 40 mg base, powder, vial, fr infusionOMEPRAZOLE, 10 mg, disp. gastro-resistant tab.OMEPRAZOLE, 20 mg, gastro-resistant caps.

■ 17.2. Antiemetic medicinesDEXAMETHASONE phosphate, 4 mg/ml, 1 ml, amp.METOCLOPRAMIDE hydrochloride anhydrous, 10 mg, tab.METOCLOPRAMIDE hydrochloride, 5 mg/ml, 2 ml, amp.ONDANSETRON HCl, eq. 4mg/5ml base, oral sol., 50ml, bot.ONDANSETRON hydrochloride, eq. 2mg/ml base, 2 ml, amp.ONDANSETRON hydrochloride, eq. 4 mg base, tab.ONDANSETRON hydrochloride, eq. 8 mg base, tab.PROMETHAZINE hydrochloride, eq. 25 mg base, tab.PROMETHAZINE hydrochloride, eq. 25 mg/ml base, 2 ml, amp.

■ 17.3. Anti-inflammatory medicinesANTIHAEMORROID, ointment, 25 g, tube

■ 17.4. LaxativesBISACODYL, 5 mg, tab.

■ 17.5. Medicines used in diarrhoea

17.5.1. Oral rehydrationORAL REHYDRATION SALTS (ORS) low osmol., sachet 20.5 g/1lRESOMAL, rehydration acute complic. malnut., sach. 84g/2l

17.5.2. Medicines for diarrhoea in childrenZINC sulfate, eq. to 20 mg zinc mineral, dispersible tab.

17.5.3. Antidiarrhoeal (symptomatic) medicines in adultsLOPERAMIDE hydrochloride, 2 mg, caps.LOPERAMIDE hydrochloride, 2 mg, tab.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 15

LABEL

INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 16: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

SECTION 18: HORMONES, OTHER ENDOCRINE MEDICINES AND CABERGOLINE, 0.5 mg, break. tab.

■ 18.3. Contraceptives

18.3.1. Oral hormonal contraceptivesDESOGESTREL 0.075 mg, tab,ETHINYLESTR. 0.03 mg / LEVONORGESTREL 0.15 mg, blister 28tabLEVONORGESTREL, 0.03 mg, tab.LEVONORGESTREL, 1.5 mg, tab.

18.3.2. Injectable hormonal contraceptivesMEDROXYPROGESTERONE acetate, 150 mg, 1 ml, syringeMEDROXYPROGESTERONE acetate, 150 mg, 1 ml, vial

18.3.3. Intrauterine devicesINTRA UTERINE DEVICE, (I.U.D.), copper, TCU 380 A

18.3.4. Barrier methodsCONDOM, lubricated + RESERVOIR, s.u.FEMALE CONDOM, lubricated, 170 mm, s.u.

18.3.5. Implantable contraceptivesETONOGESTREL implant 1 x 68 mg, with applicator s.u.LEVONORGESTREL implant 2 x 75 mg (Jadelle) + trocar

■ 18.5. Insulins and other medicines used for diabetesGLIBENCLAMIDE, 5 mg, breakable tab.GLICLAZIDE, 80mg, breakable tab.INSULIN HUMAN, BIPHASIC 30-70 IU/ml, 10ml, vial LINSULIN HUMAN, BIPHASIC 30-70 IU/ml, 10ml, vial NINSULIN HUMAN, ISOPHANE (NPH) 100 UI/ml, 10 ml, vial NINSULIN HUMAN, RAPID 100 IU/ml, 10 ml, vial NMETFORMIN hydrochloride, 500 mg, tab.

■ 18.8. Thyroid hormones and antithyroid medicinesLEVOTHYROXINE sodium, 0.1 mg, tab.

SECTION 19: IMMUNOLOGICALS

■ 19.1. Diagnostic agentsTUBERCULIN, 5 TU/0.1 ml, multidose, 1 dose, vial.

■ 19.2. Sera and immunoglobulinsIMMUNOGLOBULIN SNAKE ANTIVENOM, African countr., 10ml amp.

■ 19.3. VaccinesVACCINE BCG, 1 dose, multidose vial, 0.05 ml/dose(vaccine BCG) DILUENT, 1 dose, multidose vial

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières16

LABEL

Page 17: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

VACCINE CHOLERA, ORAL, monodose, 1.5 ml, vialVACCINE DPT / HEPATITIS B / Hib, 1 dose, multidose vialVACCINE HEPATITIS A, 1 dose, adult, monodose, syringeVACCINE HEPATITIS B, 1 adult dose, monodose, 1 ml, vialVACCINE HEPATITIS B, 1 adult dose, monodose, syringeVACCINE HEPATITIS B, 1 adult dose, monodose, unijectVACCINE HEPATITIS B, 1 adult dose, multidose vialVACCINE HEPATITIS B, 1 child dose, multidose vialVACCINE INFLUENZA 2016/2017 North. , > 6m, 1 dose, syringeVACCINE JAPANESE ENCEPHALITIS, monodose, syringe, 0.5 mlVACCINE MEASLES, 1 dose, multidose vial(vaccine measles) DILUENT, 1 dose, multidose vialVACCINE MENINGITIS CJ A+C+W135+Y, monod.+ dil.0.5ml (Menveo)VACCINE MENINGITIS PS A+C+W135+Y, 1dose, multid.vial+diluentVACCINE MENINGOCOCCAL A CONJ. 3-24months, 1dose, multid.vial(vaccine mening. A conj. 3-24m) DILUENT, 1 dose, multidoseVACCINE MENINGOCOCCAL A CONJUGATE, 1-29years, 1dose,multid.v(vaccine mening. A conj. 1-29y) DILUENT 1 dose, multidose v.VACCINE PNEUMOCOCCAL CONJUGATE PCV10, 1 dose,vial, multidoseVACCINE PNEUMOCOCCAL CONJUGATE PCV13, monod. 0,5 ml, vialVACCINE POLIOMYELITIS, BIVALENT ORAL,1 dose, multidose vial(bivalent oral polio vaccine) DROPPERVACCINE POLIOMYELITIS, INACTIVATED, 1 dose, multidose vialVACCINE RABIES, CCV, cell culture, monodose, vialVACCINE ROTAVIRUS, ORAL (Rotarix), monodose, 1,5ml, tubeVACCINE TT (tetanus), 1 dose, multidose vialVACCINE TYPHOID polysaccharide 25µg, monodosis,0.5ml,syringeVACCINE TYPHOID, "Typhim Vi", 1 dose, multidose vialVACCINE Td (tetanus/diphtheria booster) monodose 0.5ml, syrVACCINE Td (tetanus/diphtheria booster)1 dose,multidose vialVACCINE YELLOW FEVER, 1 dose, multidose vial(vaccine yellow fever) DILUENT, 1 dose, multidose vial

SECTION 20: MUSCLE RELAXANTS AND CHOLINESTERASE ATRACURIUM besilate, 10 mg/ml, 2.5 ml, amp.NEOSTIGMINE methylsulfate, 2.5 mg/ml, 1 ml, amp.SUXAMETHONIUM chloride, 50 mg/ml, 2 ml, amp.VECURONIUM bromide, 10 mg, powder, vialVECURONIUM bromide, 4 mg, powder + solvent, vial

SECTION 21: OPHTHALMOLOGICAL PREPARATIONS

■ 21.1. Anti-infective agentsACICLOVIR, 3%, eye ointment, sterile, 4.5 g, tubeCHLORAMPHENICOL, 0.5%, eye drops, sterile, 10 ml, bot.DEXAMETHASONE 5 mg / NEOMYCINE 17500 IU, eye drops, 5ml, botDEXAMETHASONE 5 mg / TOBRAMYCIN 15 mg, eye drops, 5 ml, botTETRACYCLINE hydrochloride, 1%, eye ointment, ster, 5g, tube

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 17

LABEL

INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 18: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

■ 21.2. Anti-inflammatory agentsDEXAMETHASONE 5 mg / NEOMYCINE 17500 IU, eye drops, 5ml, botDEXAMETHASONE 5 mg / TOBRAMYCIN 15 mg, eye drops, 5 ml, bot

■ 21.3. Local anaestheticsOXYBUPROCAINE, 0.4 %, eye drops, ster, 0.5 ml, unidose, amp.

■ 21.4. Miotics and antiglaucoma medicinesACETAZOLAMIDE, 250 mg, tab.PILOCARPINE hydrochloride, 2%, eye drops, sterile, 10ml, bot

■ 21.5. MydriaticsATROPINE sulfate, 1%, eye drops, ster, 0.4 ml, unidose, amp.

SECTION 22: OXYTOCICS AND ANTIOXYTOCICS

■ 22.1. OxytocicsDINOPROSTONE, 1 mg, vaginal gel, sterileMETHYLERGOMETRINE maleate, 0.2 mg/ml, 1 ml, amp.MIFEPRISTONE, 200 mg, tab.MISOPROSTOL, 200 µg, tab.OXYTOCIN, 10 IU/ml, 1 ml, amp.

■ 22.2. AntioxytocicsNIFEDIPINE, 10 mg, immediate release soft caps.NIFEDIPINE, 10 mg, immediate release tab.

SECTION 24: MEDICINES FOR MENTAL AND BEHAVIOURAL

■ 24.1. Medicines used in psychotic disordersCHLORPROMAZINE hydrochloride, 100 mg, tab.CHLORPROMAZINE hydrochloride, eq. 25 mg base, tab.CHLORPROMAZINE, 25 mg/ml, 2 ml, amp.FLUPHENAZINE decanoate, 25mg/ml, 1ml, amp.HALOPERIDOL 0.5mg, tab.HALOPERIDOL decanoate, 50mg/ml, 1ml, amp.HALOPERIDOL, 2 mg/ml, oral sol., 100 ml, bot. with pipetteHALOPERIDOL, 5 mg, tab.HALOPERIDOL, 5 mg/ml, 1 ml, amp.OLANZAPINE, 2.5 mg, tab.OLANZAPINE, 5mg, tab.RISPERIDONE, 1 mg, tab.RISPERIDONE, 2 mg, tab.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières18

LABEL

Page 19: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

■ 24.2. Medicines used in mood disorders

24.2.1. Medicines used in depressive disordersAMITRIPTYLINE hydrochloride, 25 mg, tab.FLUOXETINE hydrochloride, eq. 20 mg base, caps.IMIPRAMINE hydrochloride, 10 mg, tab.PAROXETINE, 20 mg, breakable tab.SERTRALINE, 100mg, tab.SERTRALINE, 50mg, tab.

24.2.2. Medicines used in bipolar disordersCARBAMAZEPINE, 200 mg, tab.VALPROATE SODIUM, 200 mg, gastro-resistant tab.VALPROATE SODIUM, 500 mg, gastro-resistant tab.

■ 24.3. Medicines for anxiety disordersDIAZEPAM, 2mg, tab.DIAZEPAM, 5 mg, tab.HYDROXYZINE dihydrochloride, 25 mg, tab.

SECTION 25: MEDICINES ACTING ON THE RESPIRATORY TRACT

■ 25.1. Antiasthmatic and medicines for chronic obstructive BECLOMETASONE dipropionate, 0.05mg/puff, 200 puffs,aerosolBECLOMETASONE dipropionate, 0.10mg/puff, 100 puffs,aerosolBECLOMETASONE dipropionate, 0.10mg/puff, 200 puffs,aerosolEPINEPHRINE (adrenaline) tartrate, eq.1mg/ml base,1ml amp IMEPINEPHRINE (adrenaline) tartrate,eq.1 mg/ml base,1ml amp IVIPRATROPIUM bromide, 0.125mg/ml, 2ml, sol. for nebuliserIPRATROPIUM bromide, 0.250mg/ml, 1ml, sol. for nebuliserIPRATROPIUM bromide, 0.250mg/ml, 2ml, sol. for nebuliserNOREPINEPHRINE (noradrenaline) tartrate,eq.1mg/ml base,4mlSALBUTAMOL sulfate, eq. 0.5 mg/ml base, 1 ml, amp.SALBUTAMOL sulfate, eq.0.1mg base/puff, 200 puffs, aerosolSALBUTAMOL, solution for nebulizer, 2 mg/ml, 2.5ml monodoseSODIUM chloride 6%, for nebulizer, 4 ml, vial

SECTION 26: SOLUTIONS CORRECTING WATER, ELECTROLYTE AND

■ 26.1. OralORAL REHYDRATION SALTS (ORS) low osmol., sachet 20.5 g/1lPOTASSIUM chloride, 600 mg, prolonged-release tab.POTASSIUM chloride, 7.5% w/v, 1mmol K/ml,oral sol.,500ml,botRESOMAL, rehydration acute complic. malnut., sach. 84g/2l

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières 19

LABEL

INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 20: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

■ 26.2. ParenteralDEXTROSE (GLUCOSE), 10%, 250 ml, flex. bag, PVC freeDEXTROSE (GLUCOSE), 10%, 250 ml, semi-rigid bot., PVC freeDEXTROSE (GLUCOSE), 10%, 500 ml, flex. bag, PVCDEXTROSE (GLUCOSE), 10%, 500 ml, flex. bag, PVC freeDEXTROSE (GLUCOSE), 10%, 500 ml, semi-rigid bot., PVC freeDEXTROSE (GLUCOSE), 5%, 1 l, flex. bag, PVCDEXTROSE (GLUCOSE), 5%, 1 l, flex. bag, PVC freeDEXTROSE (GLUCOSE), 5%, 1 l, semi-rigid bot., PVC freeDEXTROSE (GLUCOSE), 5%, 500 ml, flex. bag, PVCDEXTROSE (GLUCOSE), 5%, 500 ml, flex. bag, PVC freeDEXTROSE (GLUCOSE), 5%, 500 ml, semi-rigid bot., PVC freeDEXTROSE 5%/ RINGER LACTATE , 500ml, flex. bag, PVC freeGLUCOSE hypertonic, 10%, 10 ml, ampGLUCOSE hypertonic, 50%, 50 ml, vialPOTASSIUM chloride, 100 mg/ml, 10 ml, amp.RINGER lactate, 1 l, flex. bag, PVCRINGER lactate, 1 l, flex. bag, PVC freeRINGER lactate, 1 l, semi-rigid bot., PVC freeRINGER lactate, 500 ml, flex. bag, PVCRINGER lactate, 500 ml, flex. bag, PVC freeRINGER lactate, 500 ml, semi-rigid bot., PVC freeSODIUM BICARBONATE, 8.4%, 1 mEq/ml, 20 ml, amp.SODIUM chloride, 0.9%, 1 l, flex. bag, PVCSODIUM chloride, 0.9%, 1 l, flex. bag, PVC freeSODIUM chloride, 0.9%, 1 l, semi-rigid bot., PVC freeSODIUM chloride, 0.9%, 100 ml, flex. bag, PVCSODIUM chloride, 0.9%, 100 ml, flex. bag, PVC freeSODIUM chloride, 0.9%, 100 ml, semi-rigid bot., PVC freeSODIUM chloride, 0.9%, 250 ml, flex. bag, PVCSODIUM chloride, 0.9%, 250 ml, flex. bag, PVC freeSODIUM chloride, 0.9%, 250 ml, semi-rigid bot., PVC freeSODIUM chloride, 0.9%, 5 ml, amp.SODIUM chloride, 0.9%, 500 ml, flex. bag, PVCSODIUM chloride, 0.9%, 500 ml, flex. bag, PVC freeSODIUM chloride, 0.9%, 500 ml, semi-rigid bot., PVC free

■ 26.3. MiscellaneousWATER FOR INJECTION, 100 ml, flex.bag, PVCWATER FOR INJECTION, 100 ml, flex.bag, PVC freeWATER FOR INJECTION, 100 ml, semi-rigid bot., PVC freeWATER FOR INJECTION, 250 ml, flex.bag, PVCWATER FOR INJECTION, 250 ml, flex.bag, PVC freeWATER FOR INJECTION, 250 ml, semi-rigid bot., PVC freeWATER for injection, 10 ml, plastic amp.

DRUGS BY THERAPEUTIC GROUP

Copyright Médecins Sans Frontières20

LABEL

Page 21: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

SECTION 27: VITAMINS AND MINERALSASCORBIC acid (vitamin C), 250 mg, tab.ASCORBIC acid (vitamin C), 500 mg, tab.CALCIUM GLUCONATE, 100 mg/ml, 10 ml, amp.CALCIUM carbonate, eq. 500 mg Ca, chewable tab.CALCIUM carbonate, eq. 600 mg Ca, chewable tab.COLECALCIFEROL (vit.D3) 10,000 IU/ml, sol., 10 ml, bot.IODIZED OIL, 190 mg, caps.MAGNESIUM oxide, 300 mg, tab.MULTIPLE MICRONUTRIENTS SUPPLEMENTS, tab.MULTIVITAMINS, tab.NICOTINAMIDE (vitamin PP), 100 mg, tab.PYRIDOXINE hydrochloride (vitamin B6), 10 mg, tab.PYRIDOXINE hydrochloride (vitamin B6), 50 mg, tab.RETINOL (vitamin A) stabil., 200,000 IU, soft gelat. caps.THIAMINE (vitamin B1), 50 mg/ml, 2 ml, amp.THIAMINE hydrochloride (vitamin B1), 50 mg, tab.

SECTION 28: EAR, NOSE AND THROAT CONDITIONS CHILDRENCIPROFLOXACIN, 0.3%, ear/eye drops, sterile, bot.

SECTION 29: SPECIFIC MEDICINES FOR NEONATAL CARE

■ 29.1. Medicines administered to the neonateCAFFEINE CITRATE, 10mg/ml, eq. 5 mg caffeine base, 1ml, amp.CAFFEINE CITRATE, 20mg/ml eq. 10 mg caffeine base, 1ml, amp.CHLORHEXIDINE digluconate 7.1%, gel, 20g tube

■ 29.2. Medicines administered to the motherDEXAMETHASONE phosphate, 4 mg/ml, 1 ml, amp.

SECTION 30: MEDICINES FOR DISEASES OF JOINTS

■ 30.2. Disease modifying agents used in rheumatoid disorders CHLOROQUINE, 100 mg base, (161 mg phosphate), tab.CHLOROQUINE, 155 mg base, (250 mg phosphate), tab.

■ 30.3. Juvenile joint diseasesACETYLSALICYLIC acid (aspirin), 300 mg, tab.ACETYLSALICYLIC acid (aspirin), 500 mg, tab.

LABEL

Copyright Médecins Sans Frontières 21 INDE

XIX

. LIS

TSVI

II. S

DDC

VII.

EDDC

VI. D

EXO

V. D

EXT

IV. D

VAC

III. D

INF

II. D

INJ

I. DO

RAIN

TRO

Page 22: DRUGS BY THERAPEUTIC GROUPDRUGS BY THERAPEUTIC GROUP You will find hereafter the medicines used by MSF sorted according to the WHO Therapeutic Groups classification LABEL

Recommended